13 results

341 Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
Maryam Nakhjavani, Jennifer E Hardingham, Helen M Palethorpe, Tim J Price, Amanda R Townsend
KMSID: 1136977   J Breast Cancer. 2019;22(3):341-361.   Published online 2019 September 2    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e39
         
362 Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling
Byung-Hak Kim, Eun Hee Yi, Yu-Chen Li, In-Chul Park, Jung Youl Park, Sang-Kyu Ye
KMSID: 1136978   J Breast Cancer. 2019;22(3):362-374.   Published online 2019 August 2    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e34
         
375 In Vitro and In Vivo Study on the Effect of Lysosome-associated Protein Transmembrane 4 Beta on the Progression of Breast Cancer
Deyou Tao, Junqing Liang, Yihong Pan, Yanting Zhou, Ying Feng, Lin Zhang, Jingjing Xu, Hui Wang, Ping He, Jie Yao, Yang Zhao, Qinjie Ning, Wen Wang, Wei Jiang, Jing Zheng, Xia Wu
KMSID: 1136979   J Breast Cancer. 2019;22(3):375-386.   Published online 2019 September 27    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e43
         
387 Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen
Soo Yeon Baek, Ji Yeong Kwon, Young Joo Lee, Sung-chan Gwark, Sae Byul Lee, Jisun Kim, Il Yong Chung, Beom Seok Ko, Hee Jeong Kim, Sung-Bae Kim, Seung Do Ahn, Gyungyub Gong, Byung Ho Son, Sei-Hyun Ahn, Jong Won Lee
KMSID: 1136980   J Breast Cancer. 2019;22(3):387-398.   Published online 2019 August 1    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e33
         
399 Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast Cancer
Qiong Fang, Jiahui Huang, Lu Gan, Kunwei Shen, Xiaosong Chen, Beiwen Wu
KMSID: 1136981   J Breast Cancer. 2019;22(3):399-411.   Published online 2019 August 26    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e37
         
412 Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype− Breast Cancer
Hyung Suk Kim, Tae Kyung Yoo, Woo Chan Park, Byung Joo Chae
KMSID: 1136982   J Breast Cancer. 2019;22(3):412-424.   Published online 2019 August 19    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e35
         
425 The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer
Hee Yeon Kim, Tae Hyun Kim, Hye Kyoung Yoon, Anbok Lee
KMSID: 1136983   J Breast Cancer. 2019;22(3):425-438.   Published online 2019 September 18    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e41
         
439 Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
Ji Won Woo, Yul Ri Chung, Soomin Ahn, Eunyoung Kang, Eun-Kyu Kim, Se Hyun Kim, Jee Hyun Kim, In Ah Kim, So Yeon Park
KMSID: 1136984   J Breast Cancer. 2019;22(3):439-452.   Published online 2019 September 2    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e38
         
453 Measuring Tumor Extent Based on Subtypes Using Magnetic Resonance Imaging: Radiologic-Pathologic Discordance and High Positive Margin Rates in Breast Cancer
Soong June Bae, Sung Gwe Ahn, Chang Ik Yoon, Ban Seok Yang, Hak Woo Lee, Eun Ju Son, Joon Jeong
KMSID: 1136985   J Breast Cancer. 2019;22(3):453-463.   Published online 2019 August 21    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e36
         
464 Gastric Complications after Adjuvant Radiotherapy for Breast Cancer
Won Kyung Cho, Doo Ho Choi, Won Park, Haeyoung Kim, Seonwoo Kim, Myung-Hee Shin, Hyejung Cha
KMSID: 1136986   J Breast Cancer. 2019;22(3):464-471.   Published online 2019 September 23    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e42
         
472 Early Rehabilitation after Total Mastectomy and Immediate Reconstruction with Tissue Expander Insertion in Breast Cancer Patients: A Retrospective Case-control Study
Kyou Hyun Kim, Seung Mi Yeo, In Yae Cheong, Yoon Kim, Byung Joon Jeon, Ji Hye Hwang
KMSID: 1136987   J Breast Cancer. 2019;22(3):472-483.   Published online 2019 September 5    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e40
         
484 Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma
Jeongshin An, Youngeun Yoo, Hyun Goo Kim, Joohyun Woo, Kyoung Eun Lee, Hyungju Kwon, Woosung Lim, Sun Hee Sung, Nam Sun Paik, Byung-In Moon
KMSID: 1136988   J Breast Cancer. 2019;22(3):484-490.   Published online 2019 July 3    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e31
         
491 Primary Histiocytic Sarcoma Presenting as a Breast Mass: A Case Report
Seongsik Bang, Yeseul Kim, Min Sung Chung, Jeong Seon Park, Yun Young Choi, Su-Jin Shin
KMSID: 1136989   J Breast Cancer. 2019;22(3):491-496.   Published online 2019 July 31    DOI: http://dx.doi.org/10.4048/jbc.2019.22.e32
         
Articles from Journal of Breast Cancer are provided here courtesy of Korean Breast Cancer Society